Art. 30 Regulation (EU) 2016/161

Actions to be taken by persons authorised or entitled to supply medicinal products to the public in case of suspected falsification

In forcesince 2 Oct 2015cited 5×

Where persons authorised or entitled to supply medicinal products to the public have reason to believe that the packaging of the medicinal product has been tampered with, or the verification of the safety features of the medicinal product indicates that the product may not be authentic, those persons authorised or entitled to supply medicinal products to the public shall not supply the product and shall immediately inform the relevant competent authorities.

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Such resistance may exist, in particular, to the packaging of medicinal products whose anti-tampering devices have been replaced. That is particularly so since Articles 10, 24 and 30 of Delegated Regulation 2016/161 place on wholesalers …

    13 Jan 2022 · 62020CC0147

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    Under Article 30 of that delegated regulation, entitled ‘Actions to be taken by persons authorised or entitled to supply medicinal products to the public in case of suspected falsification’: ‘Where persons authorised or entitled to …

    17 Nov 2022 · 62020CJ0224

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Bayer Intellectual Property GmbH v kohlpharma GmbH.Decision

    Under Article 30 of that delegated regulation, entitled ‘Actions to be taken by persons authorised or entitled to supply medicinal products to the public in case of suspected falsification’: ‘Where persons authorised or entitled to …

    17 Nov 2022 · 62020CJ0204

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Under Article 30 of that delegated regulation, entitled ‘Actions to be taken by persons authorised or entitled to supply medicinal products to the public in case of suspected falsification’: ‘Where persons authorised or entitled to …

    17 Nov 2022 · 62020CJ0147

  • Arrêté du 26 février 2021 modifiant l'arrêté du 28 novembre 2016 relatif aux bonnes prat…Law

    … les modalités des dispositifs de sécurité figurant sur l'emballage des médicaments à usage humain, notamment ses articles 25, 26, 27, 28, 29 et 30 ; Vu le code de la santé publique, notamment son article L. 5121-5 ; Vu l'ordonnance …